ArticleNPJ breast cancer2026

Agonistic CD40 elicits CD8+ T-cell-dependent primary responses and CD4+ T-cell-dependent long-term immunity in breast cancer.

Casey Lam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.